$GBSN (Great Basin Scientific, Inc.)

$GBSN {{ '2016-09-15T10:09:23+0000' | timeago}} • Announcement

The reverse stock split will reduce $GBSN's outstanding common stock from about 78.4MM shares to about 1MM shares. The reverse stock split will affect all holders of company's common stock uniformly, and will not affect any stockholder's percentage ownership interest in the company or proportionate voting power.

$HOLX {{ '2018-01-16T13:05:50+0000' | timeago}} • Announcement

$HOLX said its CE-marked Aptima HIV-1 Quant Dx assay has been awarded World Health Organization (WHO) prequalification for in vitro diagnostic. The Aptima HIV-1 Quant Dx assay is the first HIV-1 viral load assay with a dual claim for both diagnosis and treatment monitoring.

$ILMN {{ '2018-01-16T12:42:12+0000' | timeago}} • Announcement

Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, appointed Dawn Barry as president. Previously, Barry served as the VP of Applied Genomics at $ILMN.

$HOLX {{ '2018-01-11T21:23:15+0000' | timeago}} • Announcement

Medical technology company $HOLX has elected Namal Nawana to its board of directors, effective immediately. Nawana was formerly the CEO of Alere, Inc. Prior to that, he served Johnson & Johnson in various leadership roles, including Worldwide President of DePuy Synthes Spine.

$VVV {{ '2018-01-09T13:57:44+0000' | timeago}} • Announcement

$VVV, a producer of automotive lubricants, has appointed Brad Patrick as Chief People and Communications Officer. Patrick, who joins the company from Tempur Sealy International, will report to Valvoline's CEO Sam Mitchell. Previously, Patrick held key HR positions at Sara Lee, The Gillette, Delta Air Lines and Frito-Lay.

$TMO {{ '2018-01-09T12:43:22+0000' | timeago}} • Announcement

$TMO, a leading medical technology company, has signed an agreement with life sciences firm $ILMN, under which Thermo Fisher will provide Illumina with Ion AmpliSeq technology. The tie-up will help Illumina effectively sell Ion AmpliSeq technology to researchers engaged in scientific studies on its next-generation sequencing (NGS) platforms.

$HOLX {{ '2018-01-08T13:10:32+0000' | timeago}} • Announcement

Medical technology company $HOLX said it is currently looking for net revenues of about $791MM for the first quarter of 2018, higher than $775MM-$790MM the company had estimated earlier. The latest guidance represents an 8% YoY growth, reflecting the effect of divestiture of Hologic’s blood screening business and acquisition of Cynosure.

$HOLX {{ '2018-01-03T13:10:03+0000' | timeago}} • Announcement

$HOLX said the MyoSure MANUAL device, which was designed to simplify tissue removal procedures regardless of setting, has received CE mark in Europe. The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products that offer simple and effective solutions to resect and remove tissue.

$JNJ {{ '2018-01-02T19:20:09+0000' | timeago}} • Announcement

$JNJ declared a cash dividend for 1Q18 of $0.84 per share on the company's common stock. The dividend is payable on March 13, 2018 to shareholders as on Feb 27, 2018.

$BDX {{ '2017-12-29T16:54:30+0000' | timeago}} • Announcement

$BDX acquired $BCR. Beginning with 2Q18, $BDX will report a new Interventional segment structure, which will include a majority of Bard offerings, with the remainder being reported under the Medical segment.

$BDX {{ '2017-12-29T16:54:14+0000' | timeago}} • Announcement

$BDX has acquired $BCR. $BDX does not expect the acquisition to have a material impact on its financial results in 1Q18. $BDX expects the transaction to generate low-single digit accretion to adjusted EPS in FY18, and high-single digit accretion in FY19.

$BDX {{ '2017-12-29T16:53:59+0000' | timeago}} • Announcement

$BDX completed the acquisition of $BCR. Under the terms of the transaction, Bard became a wholly owned subsidiary of $BDX, and each outstanding share of Bard common stock was converted to the right to receive $222.93 in cash without interest, and 0.5077 of a share of $BDX common stock. Bard shares will cease trading and be delisted from the NYSE.

$BDX {{ '2017-12-28T12:35:48+0000' | timeago}} • Announcement

$BDX gets clearance from the Ministry of Commerce of the People's Republic of China (MOFCOM) to acquire $BCR. BD and Bard expect the proposed acquisition to close on Dec. 29. Separately, BD's proposed divestiture of its soft tissue core needle biopsy product line to Merit Medical is conditioned on MOFCOM approval of Merit as the purchaser.

$JNJ {{ '2017-12-21T18:10:50+0000' | timeago}} • Announcement

Janssen Biotech, a $JNJ company, said the FDA has granted Priority Review designation for the New Drug Application (NDA) for apalutamide as treatment for non-metastatic castration-resistant prostate cancer (CRPC). This is the first agent submitted for approval to treat earlier stage castration-resistant prostate cancer at high risk for metastasis.

$ABT {{ '2017-12-15T16:46:17+0000' | timeago}} • Announcement

$ABT increased the company's quarterly common dividend to $0.28 per share from $0.265 per share.  The cash dividend is payable Feb. 15, 2018, to shareholders of record at the close of business on Jan. 12, 2018.

$LMNX {{ '2017-12-13T22:09:07+0000' | timeago}} • Announcement

$LMNX declared a cash dividend for 4Q17 of $0.06 per share of common stock payable on January 12, 2018 to stockholders of record on December 22, 2017.

$BIVV {{ '2017-12-11T20:56:54+0000' | timeago}} • Announcement

Biotechnology company $BIVV said results of the latest study conducted on its class monoclonal antibody BIVV009, indicated for the treatment of cold agglutinin disease,  achieved the primary and secondary endpoints. The endpoints included tolerability, pharmacokinetic profile supporting biweekly dosing, and classical complement pathway inhibition.

$BIVV {{ '2017-12-11T16:32:18+0000' | timeago}} • Announcement

$BIVV and Swedish Orphan Biovitrum AB said new data showed that individualized dosing with extended half-life therapy, Alprolix, every 14 or more days may be a potential option for people with severe hemophilia B who seek the benefits of protection from a prophylactic therapy with reduced treatment burden.

$ILMN {{ '2017-12-11T15:09:10+0000' | timeago}} • Announcement

$ILMN said Aimee Hoyt will head its human resources team. Hoyt will join as SVP and Chief People Officer (CPO), starting Jan. 8, 2018, and will be responsible for leading all aspects of the company’s HR strategies, reporting to CEO Francis deSouza.

$DIS {{ '2017-12-08T11:53:58+0000' | timeago}} • Announcement

$DIS' BoD elected two new directors: Safra Catz, CEO of global-technology leader $ORCL, and Francis deSouza, President and CEO of biotechnology firm $ILMN. The elections of Catz and deSouza are effective Feb. 1, 2018.

$AOBC {{ '2017-12-07T23:34:23+0000' | timeago}} • Announcement

$AOBC now sees 3Q18 net sales of $170-180MM generating a GAAP EPS of $0.01-0.04 and adjusted EPS of $0.07-0.10. For FY18, the firearm maker expects net sales of $650-675MM generating a GAAP EPS of $0.33-0.43 and adjusted EPS of $0.57-0.67.

Recent Transcripts

AOBC (American Outdoor Brands Corporation)
Thursday, December 7 2017 - 10:00pm
DVMT (Dell Technologies Inc.)
Thursday, December 7 2017 - 1:00pm
HOME (At Home Group Inc.)
Wednesday, November 29 2017 - 9:30pm
VREX (Varex Imaging Corporation)
Thursday, November 9 2017 - 10:00pm
VVV (Valvoline Inc.)
Thursday, November 9 2017 - 2:00pm
HOLX (Hologic Inc.)
Wednesday, November 8 2017 - 9:30pm
QGEN (Qiagen NV)
Tuesday, November 7 2017 - 2:00pm
GNMK (GenMark Diagnostics, Inc.)
Thursday, November 2 2017 - 8:30pm
AXDX (Accelerate Diagnostics, Inc.)
Thursday, November 2 2017 - 8:15pm
BHF (Brighthouse Financial, Inc.)
Thursday, November 2 2017 - 4:00pm
BDX (Becton, Dickinson and Company)
Thursday, November 2 2017 - 12:00pm
DWDP (DowDuPont Inc.)
Thursday, November 2 2017 - 12:00pm
QDEL (Quidel Corp.)
Wednesday, November 1 2017 - 9:00pm
LMNX (Luminex Corporation)
Monday, October 30 2017 - 8:30pm
BIVV (Bioverativ Inc.)
Friday, October 27 2017 - 12:00pm
ITGR (Integer Holdings Corporation)
Thursday, October 26 2017 - 9:00pm
ILMN (Illumina Inc.)
Tuesday, October 24 2017 - 9:00pm
ABT (Abbott Laboratories)
Wednesday, October 18 2017 - 1:00pm
JNJ (Johnson & Johnson)
Tuesday, October 17 2017 - 12:30pm
AOBC (American Outdoor Brands Corporation)
Thursday, September 7 2017 - 9:00pm

AlphaGraphics you may like